Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 9/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.43 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 3-Methylpyridine SCHEMBL10530 | 1.00 | — | — | |
| 3-Methylpyridine SCHEMBL29361018 | 1.00 | — | — | |
| 3-Methylpyridine SCHEMBL5319498 | 0.97 | — | — | |
| 3-Methylpyridine SCHEMBL4759127 | 0.97 | — | — | |
| 3-Methylpyridine SCHEMBL11417673 | 0.97 | CYP2A6 (0.52) | CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E | |
| 3-Methylpyridine SCHEMBL10867006 | 0.97 | — | — | |
| 3-Methylpyridine SCHEMBL6514889 | 0.97 | — | — | |
| 3-Methylpyridine SCHEMBL6509626 | 0.97 | — | — | |
| 3-Methylpyridine SCHEMBL3957265 | 0.97 | — | — | |
| 3-Methylpyridine SCHEMBL493021 | 0.97 | CYP2A6 (0.52) | CYP2A6CYP3A4ALDH1A1CYP1A2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8344150-B2 | Pyrrole end-capped bipyridine assay powder for selective detection of zinc ions and a process for the preparation thereof | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2013-01-01 | — | — | US | claimed |
| US-20100284858-A1 | PYRROLE END-CAPPED BIPYRIDINE ASSAY POWDER FOR SELECTIVE DETECTION OF ZINC IONS AND A PROCESS FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2010-11-11 | — | — | US | claimed |
| WO-2009084007-A1 | PYRROLE END-CAPPED BIPYRIDINE ASSAY POWDER FOR SELECTIVE DETECTION OF ZINC IONS AND A PROCESS FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2009-07-09 | — | — | WO | claimed |
| CN-114569612-B | Application of bipyridine in preventing and treating silkworm maggot disease | 江苏科技大学 | 2024-02-27 | — | — | CN | disclosed |
| CN-115141138-B | Method for constructing fluoride by decarboxylation of alkyl carboxylic acid | 中山大学 | 2023-11-28 | — | — | CN | disclosed |
| CN-116253755-A | Synthesis method of diaryl borate compound | 湖南大学 | 2023-06-13 | — | — | CN | disclosed |
| CN-116217395-A | Preparation method of beta-carbonyl compound | 黄淮学院 | 2023-06-06 | — | — | CN | disclosed |
| WO-2022257986-A1 | USE OF CYP450 INHIBITOR IN INHIBITING OR KILLING MITES AND TREATING DRY EYE SYNDROME | 广州岐微生物医药科技有限公司 | 2022-12-15 | — | — | WO | disclosed |
| CN-115141138-A | Method for constructing fluoride by decarboxylation of alkyl carboxylic acid | 中山大学 | 2022-10-04 | — | — | CN | disclosed |
| CN-110416586-B | Iron-based flow battery, positive and negative electrolyte thereof and preparation method | 江西理工大学 | 2020-09-11 | — | — | CN | disclosed |
| CN-103864623-B | Integrated process for diamine production | 英威达科技公司 | 2017-04-12 | — | — | CN | disclosed |
| CN-103864623-A | Integrated process for diamine production | INVISTA TECH SARL | 2014-06-18 | — | — | CN | disclosed |
| US-8598349-B2 | Method for manufacturing conjugated aromatic compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-12-03 | — | — | US | disclosed |
| US-20110275859-A1 | METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED | 2011-11-10 | — | — | US | disclosed |
| CN-1284075-A | Novel compounds having CGMP-PDE inhibitory effect | MOCHIDA PHARM CO LTD (JP) | 2001-02-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110275859-A1 | METHOD FOR MANUFACTURING CONJUGATED AROMATIC COMPOUND | C9, H1-10, CYP1A1 | CYP2A6 182/4885CYP3A4 497/4885ALDH1A1 46/4885 |
| US-20100284858-A1 | PYRROLE END-CAPPED BIPYRIDINE ASSAY POWDER FOR SELECTIVE DETECTION OF ZINC IONS AND A PROCESS FOR THE PREPARATION THEREOF | KCNN4, KCNMA1, CACNA2D1 | CYP2A6 4267/4885CYP3A4 3690/4885ALDH1A1 1334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.